{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:32:47Z","timestamp":1780619567470,"version":"3.54.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10048-022-00690-9","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T11:30:11Z","timestamp":1649849411000},"page":"187-202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical, genetic profile and disease progression of sarcoglycanopathies in a large cohort from India: high prevalence of SGCB c.544A\u2009&gt;\u2009C"],"prefix":"10.1007","volume":"23","author":[{"given":"Mainak","family":"Bardhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram Murthy","family":"Anjanappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Polavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeramani","family":"Preethish-Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seena","family":"Vengalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saraswati","family":"Nashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamita","family":"Sanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansashree","family":"Padmanabh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Kiran","family":"Valasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Nishadham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muddasu","family":"Keerthipriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thenral S.","family":"Geetha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedam","family":"Ramprasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautham","family":"Arunachal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya Treesa","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moulinath","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9791-3639","authenticated-orcid":false,"given":"Atchayaram","family":"Nalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"issue":"1","key":"690_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0960-8966(93)E0006-G","volume":"5","author":"KMD Bushby","year":"1995","unstructured":"Bushby KMD (1995) Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC consortium on limb-girdle dystrophies. Neuromuscul Disord 5(1):71\u201374","journal-title":"Neuromuscul Disord"},{"key":"690_CR2","doi-asserted-by":"crossref","unstructured":"Chu ML, Chu ML (2018) The limb \u2013 girdle muscular dystrophies\u202f: is treatment on the horizon\u202f? Pathogenic genetic variants causing abnormal protein. Neurotherapeutics 849\u201362","DOI":"10.1007\/s13311-018-0648-x"},{"issue":"3","key":"690_CR3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ncl.2014.04.005","volume":"32","author":"MP Wicklund","year":"2014","unstructured":"Wicklund MP, Kissel JT (2014) The limb-girdle muscular dystrophies. Neurol Clin 32(3):729\u2013749. https:\/\/doi.org\/10.1016\/j.ncl.2014.04.005","journal-title":"Neurol Clin"},{"key":"690_CR4","doi-asserted-by":"publisher","unstructured":"Eymard B, Romero NB, Leturcq F, Piccolo F, Carrie A, Jeanpierre M, et al. Primary adhalinopathy ( -sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy. Neurology. 1997;48(5):1227\u201334. Available from: http:\/\/www.neurology.org\/cgi\/doi\/https:\/\/doi.org\/10.1212\/WNL.48.5.1227","DOI":"10.1212\/WNL.48.5.1227"},{"key":"690_CR5","doi-asserted-by":"crossref","unstructured":"Angelini C, Fanin M, Freda MP, Duggan DJ, Siciliano G, Hoffman EP. The clinical spectrum of sarcoglycanopathies. Neurology. 1999 [cited 2021 Nov 20];52(1):176\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/9921870\/","DOI":"10.1212\/WNL.52.1.176"},{"issue":"4","key":"690_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0960-8966(00)00207-8","volume":"11","author":"R Cagliani","year":"2001","unstructured":"Cagliani R, Comi GP, Tancredi L, Sironi M, Fortunate F, Giorda R et al (2001) Primary beta-sarcoglycanopathy manifesting as recurrent exercise-induced myoglobinuria. Neuromuscul Disord 11(4):389\u2013394","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"690_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1055\/s-2002-32374","volume":"33","author":"T Mongini","year":"2002","unstructured":"Mongini T, Doriguzzi C, Bosone I, Chiad\u00f2-Piat L, Hoffman EP, Palmucci L (2002) Alpha-sarcoglycan deficiency featuring exercise intolerance and myoglobinuria. Neuropediatrics 33(2):109\u2013111","journal-title":"Neuropediatrics"},{"issue":"1","key":"690_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/mus.25109","volume":"54","author":"B Krishnaiah","year":"2016","unstructured":"Krishnaiah B, Lee JJ, Wicklund MP, Kaur D (2016) Young girl presenting with exercise-induced myoglobinuria. Muscle Nerve 54(1):161\u2013164","journal-title":"Muscle Nerve"},{"key":"690_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/B978-0-08-045031-5.00003-7","volume":"101","author":"J Kirschner","year":"2011","unstructured":"Kirschner J, Lochm\u00fcller H (2011) Sarcoglycanopathies. Handb Clin Neurol 101:41\u201346","journal-title":"Handb Clin Neurol"},{"key":"690_CR10","doi-asserted-by":"publisher","unstructured":"Oliveira Santos M, Coelho P, Roque R, Concei\u00e7\u00e3o I. Very late-onset limb-girdle muscular dystrophy type 2D: a milder form with a normal muscle biopsy. J Clin Neurosci. 2020;72(xxxx):471\u20133. Available from: https:\/\/doi.org\/10.1016\/j.jocn.2019.12.003","DOI":"10.1016\/j.jocn.2019.12.003"},{"issue":"2","key":"690_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S0960-8966(00)00174-7","volume":"11","author":"L Politano","year":"2001","unstructured":"Politano L, Nigro V, Passamano L, Petretta V, Comi LI, Papparella S et al (2001) Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromuscul Disord 11(2):178\u2013185","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"690_CR12","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1001\/archneur.65.9.1196","volume":"65","author":"ML Sveen","year":"2008","unstructured":"Sveen ML, Thune JJ, K\u00f8ber L, Vissing J (2008) Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy. Arch Neurol 65(9):1196\u20131201","journal-title":"Arch Neurol"},{"key":"690_CR13","unstructured":"Cutroneo G, Bramanti P, Anastasi G, Bruschetta D, Favaloro A, Vermiglio G, et al. Sarcoglycans and gaba(a) receptors in rat central nervous system: an immunohistochemical study. Ital J Anat Embryol = Arch Ital di Anat ed Embriol. 2015;120(2):105\u201316."},{"issue":"3","key":"690_CR14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/mus.24741","volume":"53","author":"A Nishikawa","year":"2016","unstructured":"Nishikawa A, Mori-Yoshimura M, Segawa K, Hayashi YK, Takahashi T, Saito Y et al (2016) Respiratory and cardiac function in Japanese patients with dysferlinopathy. Muscle Nerve 53(3):394\u2013401","journal-title":"Muscle Nerve"},{"key":"690_CR15","doi-asserted-by":"crossref","unstructured":"Alonso-P\u00e9rez J, Gonz\u00e1lez-Quereda L, Bello L, Guglieri M, Straub V, Gallano P, et al. New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy. Brain. 2020;143(9):2696\u2013708. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32875335","DOI":"10.1093\/brain\/awaa228"},{"issue":"4","key":"690_CR16","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1083\/jcb.122.4.809","volume":"122","author":"JM Ervasti","year":"1993","unstructured":"Ervasti JM, Campbell KP (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122(4):809\u2013823","journal-title":"J Cell Biol"},{"issue":"5","key":"690_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/mus.20349","volume":"32","author":"E Ozawa","year":"2005","unstructured":"Ozawa E, Mizuno Y, Hagiwara Y, Sasaoka T, Yoshida M (2005) Molecular and cell biology of the sarcoglycan complex. Muscle Nerve 32(5):563\u2013576","journal-title":"Muscle Nerve"},{"issue":"1","key":"690_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0028-3886.30423","volume":"50","author":"SV Khadilkar","year":"2002","unstructured":"Khadilkar SV, Singh RK, Katrak SM (2002) Sarcoglycanopathies: a report of 25 cases. Neurol India 50(1):27\u201332","journal-title":"Neurol India"},{"key":"690_CR19","doi-asserted-by":"crossref","unstructured":"Meena AK, Sreenivas D, Sundaram C, Rajasekhar R, Sita JS, Borgohain R, et al. Sarcoglycanopathies: a clinico-pathological study. Neurol India. 2007;55(2):117\u201321. Available from: http:\/\/www.neurologyindia.com\/text.asp?2007\/55\/2\/117\/32781","DOI":"10.4103\/0028-3886.32781"},{"issue":"4","key":"690_CR20","doi-asserted-by":"publisher","first-page":"548","DOI":"10.4103\/0028-3886.162048","volume":"63","author":"A Nalini","year":"2015","unstructured":"Nalini A, Polavarapu K, Sunitha B, Kulkarni S, Gayathri N, Srinivas Bharath MM et al (2015) A prospective study on the immunophenotypic characterization of limb girdle muscular dystrophies 2 in India. Neurol India 63(4):548\u2013560","journal-title":"Neurol India"},{"issue":"4","key":"690_CR21","first-page":"446","volume":"52","author":"MC Sharma","year":"2004","unstructured":"Sharma MC, Mannan R, Singh NG, Gulati S, Kalra V, Sarkar C (2004) Sarcoglycanopathies: an enigmatic form of muscular dystrophy - a report of 7 cases. Neurol India 52(4):446\u2013449","journal-title":"Neurol India"},{"issue":"5","key":"690_CR22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.4103\/0028-3886.72164","volume":"58","author":"A Nalini","year":"2010","unstructured":"Nalini A, Gayathri N, Thaha F, Das S, Shylashree S (2010) Sarcoglycanopathy: clinical and histochemical characteristics in 66 patients. Neurol India 58(5):691\u2013696","journal-title":"Neurol India"},{"issue":"4","key":"690_CR23","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4103\/0028-3886.55603","volume":"57","author":"SV Khadilkar","year":"2009","unstructured":"Khadilkar SV, Singh RK, Hegde M, Urtizberea A, Love DR, Chong B (2009) Spectrum of mutations in sarcoglycan genes in the Mumbai region of western India: high prevalence of 525del T. Neurol India 57(4):406\u2013410","journal-title":"Neurol India"},{"key":"690_CR24","doi-asserted-by":"crossref","unstructured":"Chakravorty S, Nallamilli BRR, Khadilkar SV, Singla MB, Bhutada A, Dastur R, et al. Clinical and genomic evaluation of 207 genetic myopathies in the Indian subcontinent. Front Neurol. 2020;11(November).","DOI":"10.3389\/fneur.2020.559327"},{"issue":"5","key":"690_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Durbin R (2010) Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26(5):589\u2013595","journal-title":"Bioinformatics"},{"key":"690_CR26","doi-asserted-by":"publisher","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297\u2013303. Available from: http:\/\/genome.cshlp.org\/cgi\/doi\/https:\/\/doi.org\/10.1101\/gr.107524.110","DOI":"10.1101\/gr.107524.110"},{"key":"690_CR27","doi-asserted-by":"crossref","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201323. Available from: http:\/\/www.nature.com\/articles\/gim201530","DOI":"10.1038\/gim.2015.30"},{"issue":"10","key":"690_CR28","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/01.jnen.0000235854.77716.6c","volume":"65","author":"SA Moore","year":"2006","unstructured":"Moore SA, Shilling CJ, Westra S, Wall C, Wicklund MP, Stolle C et al (2006) Limb-girdle muscular dystrophy in the United States. J Neuropathol Exp Neurol 65(10):995\u20131003","journal-title":"J Neuropathol Exp Neurol"},{"key":"690_CR29","doi-asserted-by":"publisher","unstructured":"Carri\u00e9 A, Piccolo F, Leturcq F, de Toma C, Azibi\nK, Beldjord C et al ( 1997) Mutational\ndiversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive\nmuscular dystrophy (LGMD2D). J Med Genet. 34(6):470\u20135. https:\/\/doi.org\/10.1136\/jmg.34.6.470","DOI":"10.1136\/jmg.34.6.470"},{"key":"690_CR30","doi-asserted-by":"publisher","unstructured":"Duggan DJ, Gorospe JR, Fanin M, Hoffman EP, Angelini C. Mutations in the sarcoglycan genes in patients with myopathy. N Engl J Med. 1997;336(9):618\u201324. Available from: http:\/\/www.nejm.org\/doi\/abs\/https:\/\/doi.org\/10.1056\/NEJM199702273360904","DOI":"10.1056\/NEJM199702273360904"},{"key":"690_CR31","doi-asserted-by":"publisher","unstructured":"Xie Z, Hou Y, Yu M, Liu Y, Fan Y, Zhang W (2019) Clinical and genetic spectrum of sarcoglycanopathies in a large cohort of\nChinese patients. Orphanet J Rare Dis. 14;14(1):43. https:\/\/doi.org\/10.1186\/s13023-019-1021-9","DOI":"10.1186\/s13023-019-1021-9"},{"issue":"01","key":"690_CR32","doi-asserted-by":"publisher","first-page":"023","DOI":"10.1055\/s-0040-1713850","volume":"10","author":"G Nerakh","year":"2021","unstructured":"Nerakh G, Ranganath P, Murugan S (2021) Next-generation sequencing in a cohort of Asian Indian patients with the Duchenne muscular dystrophy phenotype: diagnostic yield and mutation spectrum. J Pediatr Genet 10(01):023\u2013028","journal-title":"J Pediatr Genet"},{"key":"690_CR33","doi-asserted-by":"publisher","unstructured":"Yu M, Zheng Y, Jin S, Gang Q, Wang Q, Yu P (2017) Mutational spectrum of Chinese LGMD patients by targeted next-generation\nsequencing. PLoS One. 12;12(4):e0175343. https:\/\/doi.org\/10.1371\/journal.pone.0175343","DOI":"10.1371\/journal.pone.0175343"},{"key":"690_CR34","doi-asserted-by":"publisher","unstructured":"Bartoli M, Gicquel E, Barrault L, Soheili T, Malissen M, Malissen B (2008) Mannosidase I inhibition\nrescues the human alpha-sarcoglycan R77C recurrent mutation. Hum Mol Genet. 1;17(9):1214\u201321. https:\/\/doi.org\/10.1093\/hmg\/ddn029","DOI":"10.1093\/hmg\/ddn029"},{"key":"690_CR35","doi-asserted-by":"publisher","unstructured":"T\u00e9treault M, Srour M, Allyson J, Thiffault I, Loisel L, Robitaille Y (2011)\u00a0Founder mutation for \u03b1-sarcoglycan-LGMD2D in a Magdalen Islands Acadian\ncluster. Can J Neurol Sci. 38(5):747\u201352. https:\/\/doi.org\/10.1017\/s0317167100054135","DOI":"10.1017\/s0317167100054135"},{"key":"690_CR36","doi-asserted-by":"publisher","unstructured":"Stehl\u00edkov\u00e1 K, Sk\u00e1lov\u00e1 D, Z\u00eddkov\u00e1 J, Mr\u00e1zov\u00e1 L, Vondr\u00e1\u010dek P, Mazanec R (2014) Autosomal recessive limb-girdle muscular\ndystrophies in the Czech Republic. BMC Neurol. 19;14:154. https:\/\/doi.org\/10.1186\/s12883-014-0154-7","DOI":"10.1186\/s12883-014-0154-7"},{"issue":"7","key":"690_CR37","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/ejhg.2008.9","volume":"16","author":"M Trabelsi","year":"2008","unstructured":"Trabelsi M, Kavian N, Daoud F, Commere V, Deburgrave N, Beugnet C et al (2008) Revised spectrum of mutations in sarcoglycanopathies. Eur J Hum Genet 16(7):793\u2013803","journal-title":"Eur J Hum Genet"},{"key":"690_CR38","doi-asserted-by":"publisher","unstructured":"Mojbafan M, Bahmani R, Bagheri SD, Sharifi Z, Zeinali S (2020) Mutational\nspectrum of autosomal recessive limb-girdle muscular dystrophies in a cohort of\n112 Iranian patients and reporting of a possible founder effect. Orphanet J Rare\nDis. 14;15(1):14. https:\/\/doi.org\/10.1186\/s13023-020-1296-x","DOI":"10.1186\/s13023-020-1296-x"},{"key":"690_CR39","doi-asserted-by":"publisher","unstructured":"Soheili T, Gicquel E, Poupiot J, N'Guyen L, Le Roy F (2012) Rescue of sarcoglycan mutations by inhibition of endoplasmic reticulum\nquality control is associated with minimal structural modifications. Hum Mutat. 33(2):429\u201339. https:\/\/doi.org\/10.1002\/humu.21659","DOI":"10.1002\/humu.21659"},{"key":"690_CR40","doi-asserted-by":"publisher","unstructured":"Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, Crosbie RH (1998) Williamson R, Campbell KP. Progressive muscular\ndystrophy in alpha-sarcoglycan-deficient mice. J Cell Biol. 21;142(6):1461\u201371. https:\/\/doi.org\/10.1083\/jcb.142.6.1461","DOI":"10.1083\/jcb.142.6.1461"},{"key":"690_CR41","doi-asserted-by":"publisher","unstructured":"Monies D, Alhindi HN, Almuhaizea MA, Abouelhoda M, Alazami AM, Goljan E (2016) A first-line diagnostic\nassay for limb-girdle muscular dystrophy and other myopathies. Hum Genomics. 27;10(1):32. https:\/\/doi.org\/10.1186\/s40246-016-0089-8","DOI":"10.1186\/s40246-016-0089-8"},{"key":"690_CR42","doi-asserted-by":"crossref","unstructured":"B\u00f6nnemann CG, Wong J, Hamida C Ben, Hamida M Ben, Hentati F, Kunkel LM. LGMD 2E in Tunisia is caused by a homozygous missense mutation in \u03b2-sarcoglycan exon 3. Neuromuscul Disord. 1998;8(3\u20134):193\u20137.","DOI":"10.1016\/S0960-8966(98)00014-5"},{"issue":"8","key":"690_CR43","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00415-019-09358-1","volume":"266","author":"A Ganapathy","year":"2019","unstructured":"Ganapathy A, Mishra A, Soni MR, Kumar P, Sadagopan M, Kanthi AV et al (2019) Multi-gene testing in neurological disorders showed an improved diagnostic yield: data from over 1000 Indian patients. J Neurol 266(8):1919\u20131926. https:\/\/doi.org\/10.1007\/s00415-019-09358-1","journal-title":"J Neurol"},{"key":"690_CR44","doi-asserted-by":"crossref","unstructured":"Semplicini C, Vissing J, Dahlqvist JR, Stojkovic T, Bello L, Witting N, et al. Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E. Neurology. 2015;84(17):1772\u201381. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25862795","DOI":"10.1212\/WNL.0000000000001519"},{"key":"690_CR45","unstructured":"Balci B, Wilichowski E, Halilo\u011flu G, Talim B, Aurino S, Kremer E (2004) Beta-sarcoglycan gene mutations in Turkey. Acta Myol. 23(3):154\u20138"},{"key":"690_CR46","unstructured":"Yi\u015f U, Diniz G, Hazan F, Daimag\u00fcler HS, Baysal BT, Baydan F (2018) Childhood onset limb girdle muscular dystrophies in the\nAegean part of Turkey. Acta Myol. 1;37(3):210\u2013220"},{"key":"690_CR47","doi-asserted-by":"publisher","unstructured":"Duncan DR, Kang PB, Rabbat JC, Briggs CE, Lidov HG, Darras BT (2006) A novel mutation in two families with limb-girdle muscular dystrophy type\n2C. Neurology. 11;67(1):167\u20139. https:\/\/doi.org\/10.1212\/01.wnl.0000223600.78363","DOI":"10.1212\/01.wnl.0000223600.78363"},{"key":"690_CR48","doi-asserted-by":"publisher","unstructured":"Al-Zaidy SA, Malik V, Kneile K, Rosales XQ, Gomez AM, Lewis S (2015) A slowly progressive form of limb-girdle muscular\ndystrophy type 2C associated with founder mutation in the SGCG gene in Puerto\nRican Hispanics. Mol Genet Genomic Med. 3(2):92\u20138. https:\/\/doi.org\/10.1002\/mgg3.125","DOI":"10.1002\/mgg3.125"},{"key":"690_CR49","doi-asserted-by":"publisher","unstructured":"DiCapua D, Patwa H (2014) Puerto Rican founder mutation G787A in the SGCG\ngene: a case report of 2 siblings with LGMD 2C. J Clin Neuromuscul Dis. 15(3):105\u20137. https:\/\/doi.org\/10.1097\/CND.0000000000000018","DOI":"10.1097\/CND.0000000000000018"},{"key":"690_CR50","doi-asserted-by":"publisher","unstructured":"Reddy HM, Cho KA, Lek M, Estrella E, Valkanas E, Jones MD (2017) The sensitivity of exome sequencing in\nidentifying pathogenic mutations for LGMD in the United States. J Hum Genet. 62(2):243\u2013252. https:\/\/doi.org\/10.1038\/jhg.2016.116","DOI":"10.1038\/jhg.2016.116"},{"key":"690_CR51","doi-asserted-by":"publisher","unstructured":"Moreira ES, Vainzof M, Marie SK, Nigro V, Zatz M, Passos-Bueno MR (1998) A\nfirst missense mutation in the delta sarcoglycan gene associated with a severe\nphenotype and frequency of limb-girdle muscular dystrophy type 2F (LGMD2F) in\nBrazilian sarcoglycanopathies. J Med Genet. 35(11):951\u20133. https:\/\/doi.org\/10.1136\/jmg.35.11.951","DOI":"10.1136\/jmg.35.11.951"},{"key":"690_CR52","doi-asserted-by":"crossref","unstructured":"Manzini MC, Tambunan DE, Hill RS, Yu TW, Maynard TM, Heinzen EL (2012) Exome sequencing and functional validation in zebrafish identify\nGTDC2 mutations as a cause of Walker-Warburg syndrome. Am J Hum Genet. 7;91(3):541\u20137. https:\/\/doi.org\/10.1016\/j.ajhg.2012.07.009","DOI":"10.1016\/j.ajhg.2012.07.009"},{"key":"690_CR53","doi-asserted-by":"publisher","unstructured":"Houlden H, Laura M, Ginsberg L, Jungbluth H, Robb SA, Blake J (2009) The phenotype of Charcot-Marie-Tooth disease type 4C due\nto SH3TC2 mutations and possible predisposition to an inflammatory neuropathy.\nNeuromuscul Disord. 19(4):264 9. https:\/\/doi.org\/10.1016\/j.nmd.2009.01.006","DOI":"10.1016\/j.nmd.2009.01.006"},{"key":"690_CR54","doi-asserted-by":"publisher","unstructured":"Varley TL, Bourque PR, Baker SK (2015) Phenotypic variability of CMT4C in a French Canadian\nkindred. Muscle Nerve. 52(3):444\u20139. https:\/\/doi.org\/10.1002\/mus.24640","DOI":"10.1002\/mus.24640"},{"issue":"1","key":"690_CR55","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1017\/cjn.2015.311","volume":"43","author":"JK Mah","year":"2015","unstructured":"Mah JK, Korngut L, Fiest KM, Dykeman J, Day LJ, Pringsheim T et al (2015) A systematic review and meta-analysis on the epidemiology of the muscular dystrophies. Can J Neurol Sci 43(1):163\u2013177","journal-title":"Can J Neurol Sci"},{"issue":"12","key":"690_CR56","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1080\/21678707.2016.1256769","volume":"4","author":"C Angelini","year":"2016","unstructured":"Angelini C, Fanin M (2016) Pathogenesis, clinical features and diagnosis of sarcoglycanopathies. Expert Opin Orphan Drugs 4(12):1239\u20131251. https:\/\/doi.org\/10.1080\/21678707.2016.1256769","journal-title":"Expert Opin Orphan Drugs"},{"issue":"12","key":"690_CR57","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1136\/jmg.34.12.973","volume":"34","author":"M Fanin","year":"1997","unstructured":"Fanin M, Duggan DJ, Mostacciuolo ML, Martinello F, Freda MP, Sorar\u00f9 G et al (1997) Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations. J Med Genet 34(12):973\u2013977","journal-title":"J Med Genet"},{"issue":"5","key":"690_CR58","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3892\/mmr.2014.2048","volume":"9","author":"OA Mahmood","year":"2014","unstructured":"Mahmood OA, Jiang XM (2014) Limb-girdle muscular dystrophies: where next after six decades from the first proposal (Review). Mol Med Rep 9(5):1515\u20131532","journal-title":"Mol Med Rep"},{"issue":"11","key":"690_CR59","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1093\/brain\/awp236","volume":"132","author":"FLM Norwood","year":"2009","unstructured":"Norwood FLM, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V (2009) Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain 132(11):3175\u20133186","journal-title":"Brain"},{"issue":"5","key":"690_CR60","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/(SICI)1096-8628(19990219)82:5<392::AID-AJMG7>3.0.CO;2-0","volume":"82","author":"MR Passos-Bueno","year":"1999","unstructured":"Passos-Bueno MR, Vainzof M, Moreira ES, Zatz M (1999) Seven autosomal recessive limb-girdle muscular dystrophies in the Brazilian population: from LGMD2A to LGMD2G. Am J Med Genet 82(5):392\u2013398","journal-title":"Am J Med Genet"},{"issue":"1","key":"690_CR61","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.nmd.2007.08.009","volume":"18","author":"HP Lo","year":"2008","unstructured":"Lo HP, Cooper ST, Evesson FJ, Seto JT, Chiotis M, Tay V et al (2008) Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis. Neuromuscul Disord 18(1):34\u201344","journal-title":"Neuromuscul Disord"},{"key":"690_CR62","doi-asserted-by":"crossref","unstructured":"Moreira ES, Vainzof M, Suzuki OT, Pavanello RC, Zatz M, Passos-Bueno MR. Genotype-phenotype correlations in 35 Brazilian families with sarcoglycanopathies including the description of three novel mutations. J Med Genet. 2003;40(2).","DOI":"10.1136\/jmg.40.2.e12"},{"key":"690_CR63","unstructured":"Pegoraro E, Hoffman EP (1993) Limb-girdle muscular dystrophy overview \u2013 RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, et al (eds) Seattle (WA)"},{"issue":"1","key":"690_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jnnp-2017-316736","volume":"89","author":"G Tasca","year":"2018","unstructured":"Tasca G, Monforte M, D\u00edaz-Manera J, Brisca G, Semplicini C, D\u2019Amico A et al (2018) MRI in sarcoglycanopathies: a large international cohort study. J Neurol Neurosurg Psychiatry 89(1):1\u20136","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"690_CR65","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/mus.25443","volume":"56","author":"I Dalichaouche","year":"2017","unstructured":"Dalichaouche I, Sifi Y, Roudaut C, Sifi K, Hamri A, Rouabah L et al (2017) \u03b3-Sarcoglycan and dystrophin mutation spectrum in an Algerian cohort. Muscle Nerve 56(1):129\u2013135","journal-title":"Muscle Nerve"},{"issue":"12","key":"690_CR66","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1093\/hmg\/5.12.2019","volume":"5","author":"F Piccolo","year":"1996","unstructured":"Piccolo F, Jeanpierre M, Leturcq F, Dod\u00e9 C, Azibi K, Toutain A et al (1996) A founder mutation in the \u03b3-sarcoglycan gene of Gypsies possibly predating their migration out of India. Hum Mol Genet 5(12):2019\u20132022","journal-title":"Hum Mol Genet"},{"issue":"3","key":"690_CR67","first-page":"732","volume":"57","author":"KB Othmane","year":"1995","unstructured":"Othmane KB, Speer MC, Stauffer J, Blel S, Middleton L, Hamida BC et al (1995) Evidence for linkage disequilibrium in chromosome 13-linked Duchenne-like muscular dystrophy (LGMD2C) [1]. Am J Hum Genet 57(3):732\u2013734","journal-title":"Am J Hum Genet"},{"key":"690_CR68","doi-asserted-by":"publisher","unstructured":"Alavi A, Esmaeili S, Nilipour Y, Nafissi S, Tonekaboni SH, Zamani G, et al. LGMD2E is the most common type of sarcoglycanopathies in the Iranian population. J Neurogenet. 2017;31(3):161\u20139. Available from: https:\/\/www.tandfonline.com\/doi\/full\/https:\/\/doi.org\/10.1080\/01677063.2017.1346093","DOI":"10.1080\/01677063.2017.1346093"},{"issue":"1","key":"690_CR69","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ajhg.2015.05.008","volume":"97","author":"R Acuna-Hidalgo","year":"2015","unstructured":"Acuna-Hidalgo R, Bo T, Kwint MP, Van De Vorst M, Pinelli M, Veltman JA et al (2015) Post-zygotic point mutations are an underrecognized source of de novo genomic variation. Am J Hum Genet 97(1):67\u201374. https:\/\/doi.org\/10.1016\/j.ajhg.2015.05.008","journal-title":"Am J Hum Genet"},{"issue":"4","key":"690_CR70","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00415-016-8036-0","volume":"263","author":"M Kuhn","year":"2016","unstructured":"Kuhn M, Gl\u00e4ser D, Joshi PR, Zierz S, Wenninger S, Schoser B et al (2016) Utility of a next-generation sequencing-based gene panel investigation in German patients with genetically unclassified limb-girdle muscular dystrophy. J Neurol 263(4):743\u2013750","journal-title":"J Neurol"},{"key":"690_CR71","doi-asserted-by":"publisher","unstructured":"Melacini P, Fanin M, Duggan DJ, Freda MP, Berardinelli A, Danieli GA, et al. Heart involvement in muscular dystrophies due to. Muscle Nerve. 1999;22(April):473\u20139. Available from: http:\/\/doi.wiley.com\/https:\/\/doi.org\/10.1002\/%28SICI%291097-4598%28199904%2922%3A4%3C473%3A%3AAID-MUS8%3E3.0.CO%3B2-5","DOI":"10.1002\/%28SICI%291097-4598%28199904%2922%3A4%3C473%3A%3AAID-MUS8%3E3.0.CO%3B2-5"}],"container-title":["neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-022-00690-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-022-00690-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-022-00690-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T16:10:27Z","timestamp":1656951027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-022-00690-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["690"],"URL":"https:\/\/doi.org\/10.1007\/s10048-022-00690-9","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,13]]},"assertion":[{"value":"29 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}